Intellia Therapeutics, Inc.

NTLA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$189,182$226,748$523,506$123,406
Short-Term Investments$412,333$685,475$669,116$625,282
Receivables$8,517$36,456$3,768$2,031
Inventory$0$0$0$0
Other Curr. Assets$29,831$49,651$20,407$18,584
Total Curr. Assets$639,863$998,330$1,216,797$769,303
Property Plant & Equip (Net)$246,673$148,135$160,997$100,111
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$44,264$154,512$142,320$425,050
Tax Assets$0$0$0$0
Other NC Assets$260,215$0$0$0
Total NC Assets$551,152$302,647$303,317$525,161
Other Assets$0$0$0$0
Total Assets$1,191,015$1,300,977$1,520,114$1,294,464
Liabilities
Payables$14,589$7,452$5,154$9,653
Short-Term Debt$20,246$18,599$16,685$9,112
Tax Payable$0$0$0$0
Deferred Revenue$20,661$22,140$43,839$63,759
Other Curr. Liab.$55,355$67,017$60,876$43,309
Total Curr. Liab.$110,851$115,208$126,554$125,833
LT Debt$189,952$96,747$114,018$64,911
Deferred Rev, NC$18,256$38,853$19,932$63,476
Deferred Tax Liab, NC$0-$38,853$0$0
Other NC Liab.$0$38,853$24,026$0
Total NC Liab.$208,208$135,600$157,976$128,387
Other Liabilities$0$0$0$0
Cap. Leases$210,198$115,346$130,703$74,023
Total Liabilities$319,059$250,808$284,530$254,220
Equity
Pref Stock$0$0$0$0
Common Stock$10$9$9$7
Retained Earnings-$2,177,400-$1,658,379-$1,177,187-$703,001
AOCI$605-$2,258-$7,461-$2,632
Other Equity$3,048,741$2,710,797$2,420,223$1,745,870
Total Equity$871,956$1,050,169$1,235,584$1,040,244
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,191,015$1,300,977$1,520,114$1,294,464
Net Debt$21,016-$111,402-$392,803-$49,383
Intellia Therapeutics, Inc. (NTLA) Financial Statements & Key Stats | AlphaPilot